Using Impedance-Based Approaches for Measuring Cell-Mediated Cytotoxicity; Antibody-Dependent (ADCC) and Chimeric Antigen Receptor T (CAR-T)

Similar documents
xcelligence Real-Time Cell Analyzers

The Application of Cell-Based Impedance Technology in Drug Discovery

System. xcelligence System RTCA HT Instrument. Application Note No. 14 /January Long-Term High-Throughput Cytotoxicity Profiling

Focus Application. Compound-Induced Cytotoxicity

Focus Application. Compound-Induced Cytotoxicity

xcelligence RTCA Cardio Instrument Monitor Cardiomyocyte Beating in Real Time for Drug Discovery Research

Measuring Cardiac Activity:

7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit

System. From Classical to Online Monitoring of G-ProteinCoupled Receptor. Stimulation in Living Cells. Application Note No.

BIOTARGET-1 SERUM-FREE MEDIUM

NATURAL KILLER T CELLS EBOOK

Assays for Immuno-oncology Research Real-time automated measurements of immune and tumor cell dynamics within your incubator

Cell Migration and Invasion Assays INCUCYTE LIVE-CELL ANALYSIS SYSTEM. Real-time automated measurements of cell motility inside your incubator

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit

Utilization of a Label-Free Real-Time Cell Analysis Technology for Cancer Immunotherapy Applications. Yama Abassi, Ph.D. VP, ACEA Biosciences

Understanding immune biomarkers for use in nutrition interventions

Antibody Dependent Cellular Cytotxic activity: Past and Future. Guido Ferrari, M.D. Duke University Medical Center

xcelligence Real-Time Cell Analyzers

InPulse: Development of an ipsc cardiomyocyte (ipsc-cm) platform to assess drug-induced contractility liabilities.

Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes. on the ACEA xcelligence RTCA CardioECR

mesc Derived Cardiomyocytes and the RTCA Cardio Instrument - The Perfect Match for Screening Cardiac Effects

NINDS Repository Human Induced Pluripotent Stem Cell (ipsc) Handling Protocols (Matrigel and mtesr Media)

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

Now Wireless. The icelligence System. RTCA Technology, Label-Free Real-Time Cellular Analysis

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Human Induced Plutipotent Stem Cell (ipsc) Handling Protocols: Matrigel and mtesr/e8 Media

Human CD4+T Cell Care Manual

PROTOCOL: OPTIMIZATION OF LENTIVIRAL TRANSDUCTION USING SPINFECTION

C. Incorrect! MHC class I molecules are not involved in the process of bridging in ADCC.

Data Sheet TIGIT / NFAT Reporter - Jurkat Cell Line Catalog #60538

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

Structure and Function of Antigen Recognition Molecules

Features & Benefits of the Oris Cell Migration Assay

Multiparametric assessment of the effects of chemotherapeutic drugs on the (electro)physiology of Pluricyte Cardiomyocytes

CANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University

Plate-Based Assay Methods for the Assessment of Cellular Health

محاضرة مناعت مدرس المادة :ا.م. هدى عبدالهادي علي النصراوي Immunity to Infectious Diseases

Immune response. This overview figure summarizes simply how our body responds to foreign molecules that enter to it.

A Membrane Receptor Binding Assay Using MesoScale Electrochemiluminescence Technology

08/02/59. Tumor Immunotherapy. Development of Tumor Vaccines. Types of Tumor Vaccines. Immunotherapy w/ Cytokine Gene-Transfected Tumor Cells

Reporter Gene Immunotherapy Bioassays

Mammalian Cell PE LB

Topics. Humoral Immune Response Part II Accessory cells Fc Receptors Opsonization and killing mechanisms of phagocytes NK, mast, eosynophils

CHARACTERIZING THE IMMUNE PHENOTYPE OF TUMOR INFILTRATING LYMPHOCYTES IN RENAL CELL CARCINOMA

Dr. C. Tom Kouroukis. New and upcoming treatments for Lymphoma

al., 1982). We have recently reported that human NK cell activity is suppressed by adherent cells from carcinomatous pleural effusions of cancer

Supplemental Information. Phase 1 Results of ZUMA-1: A Multicenter Study. of KTE-C19 Anti-CD19 CAR T Cell Therapy. in Refractory Aggressive Lymphoma

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Nonspecific External Barriers skin, mucous membranes

ulation of NK cells that retain the capability of expressing the HNK-1 differentiation antigen. Children with the Chediak-Higashi (CH)' syndrome,

Bacterial Diseases IMMUNITY TO BACTERIAL INFECTIONS. Gram Positive Bacteria. Gram Negative Bacteria. Many Infectious agents and many diseases

Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes. on the ACEA xcelligence RTCA CardioECR

axion Protocol Cell Culture on Microelectrode Arrays Cell Type: GE Healthcare - Cytiva TM Plus Cardiomyocytes BioSystems v. 1.0

Bioassays for Quality Control of Cell & Gene Therapy Products

CytoPainter Lysosomal Staining Kit - Blue Fluorescence

Case Study for ADCC and CDC Assays

IMMUNE RESPONSE TO INFECTIOUS DISEASES

Induction and Clearance of Latent HIV Infection:

Immune Surveillance. Immune Surveillance. Immune Surveillance. Neutrophil granulocytes Macrophages. M-cells

Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the ACEA xcelligence RTCA CardioECR

Immunobiology 7. The Humoral Immune Response

Anti-infectious Immunity

ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY

ANATOMY OF THE IMMUNE SYSTEM

NK cell flow cytometric assay In vivo DC viability and migration assay

Understanding basic immunology. Dr Mary Nowlan

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

Cytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands

Adaptive Immunity: Humoral Immune Responses

Islet Assay Using the Agilent Seahorse XF24 Islet Capture Microplate

Human ipsc-derived Microglial Precursors

Potency Assays Throughout Product Development: Perspectives of an FDA Reviewer

Islet Oxygen Consumption Assay using the XF24 Islet Capture Microplate Shirihai Lab and Seahorse Bioscience Aug

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214,

Human IL-2. Pre-Coated ELISA Kit

Cell Mediated Immunity CELL MEDIATED IMMUNITY. Basic Elements of Cell Mediated Immunity (CMI) Antibody-dependent cell-mediated cytotoxicity (ADCC)

10/18/2012. A primer in HLA: The who, what, how and why. What?

Introduction to Targeted Therapy

Bioactivity Assays: Putting the Puzzle Together

Tumor Immunology. Wirsma Arif Harahap Surgical Oncology Consultant

Identifying potential HCV drug leads by small molecule screening.

I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms. Table 2: Innate Immunity: First Lines of Defense

Adaptive Immune System

Topics in Parasitology BLY Vertebrate Immune System

RXi Pharmaceuticals. Immuno-Oncology World Frontiers Conference. January 23, 2018 NASDAQ: RXII. Property of RXi Pharmaceuticals

windows of my lab Prof. Allan Wiik, emeritus director Department of Autoimmunology Statens Serum Institute, Copenhagen

Advances in Cancer Immunotherapy

CAR T-CELLS: ENGINEERING IMMUNE CELLS TO TREAT CANCER. Roman GALETTO, PhD 17 th Club Phase 1 Annual Meeting April 5 th Paris

Automated manufacture of T-cell immunotherapies using gamma retroviral transduction. Lee Markwick, PhD. AMC, Manchester March 2018

Natural Killer (NK) cells and Programmed cell death protein-1 (PD-1)

IMMUNITY AND ANTIBODIES

MED64 Protocol Axol Human ipsc-derived Neural Stem Cells

Disease causing organisms Resistance Immunity

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections

The effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells

Performing Bioenergetic Analysis: Seahorse XFe96 Analyzer

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School

227 28, 2010 MIDTERM EXAMINATION KEY

Lecture 9: T-cell Mediated Immunity

Transcription:

Using Impedance-Based Approaches for Measuring Cell-Mediated Cytotoxicity; Antibody-Dependent (ADCC) and Chimeric Antigen Receptor T (CAR-T) Vashu Pamnani, PhD. Cambridge Bioscience

T Cells Non-Adherent Property is Useful in Cytolytic Assay Microelectrode Adherent Target Cells CELL-MEDIATED CYTOTOXICITY Add T Cells Dead Target Cells Cytolysis J Vis Exp. 2012 Aug 8;(66):e3683. doi: 10.3791/3683. Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xcelligence. system. Erskine CL, Henle AM, Knutson KL. Mayo Clinic, USA.

Background CMC assays - typically performed using radioactivity (Cr 51) or other labelbased assays. Target cell is labeled and then exposed to different densities of effector cells. The label is released into the supernatant when target cells are killed Drawbacks Sample processing is complex, tedious and time consuming, or involves handling of radioactivity. The label has a tendency to leach out of the cell, thus limiting the possible assay window. Necessary washing steps may damage or kill (already knocked) target cells, thus falsifying the results.

Immune-Mediated Tumor Cell Killing Cell Migration NK Assays ADCC T-Cell Activation CAR-T

Adaptive Immunity: T cell-mediated Cytotoxicity Killer T cell Activity is Dose Dependent J Vis Exp. 2012 Aug 8;(66):e3683. doi: 10.3791/3683. Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xcelligence. system. Erskine CL, Henle AM, Knutson KL. Mayo Clinic, USA.

Detection of Antibody Dependent Cell-mediated Cytolysis (ADCC) Assay Drug Dev Technol. 2006;4(5):555-63. Dynamic detection of natural killer cell-mediated cytotoxicity and cell adhesion by electrical impedance measurements. Glamann J and Hansen AJ., Novo Nordisk A/S, Denmark

xcelligence Impedence-based technology Key Benefits: Label-free - no secondary assays required, and no interference with cell function Time saving - no tedious, time-consuming sample processing at each time point, no handling of radioactivity Short to long term monitoring- there is no label to leak out of the cells and therefore No requirement for sample processing at unsociable hours (either costly or you are missing valuable data points) Can obtain kinetic data continuous, uninterrupted monitoring

xcelligence Impedence-based technology Key Benefits: Continuous QC Quality assurance for cell viability Quantitative cell number, morphology, viability Assays at Physiological conditions can be placed in a standard incubator Broad applications cell cytotox, invasion, migration, proliferation, etc..

Some Applications Compound-mediated Cytoxicity Cell Invasion and Migration Cell proliferation Cell Adhesion and Spreading Functional Monitoring of Receptor Tyrosine Kinase Signalling Functional Monitoring of GPCR Signalling IgE Receptor Function Cell Quality Barrier Function Viral Quantitation

Drug Discovery Pipeline Throughput RTCA-MP -6x 96 well RTCA-SP96-96 well RTCA-iCelligence - 2x 8 well RTCA-HT384-4x 384 well RTCA-Cardio - 96 well RTCA-DP - 16 well Specially for Migration studies

xcelligence is ideal for handling assays involving T cells targeted at tumour cell xcelligence will detect adherent cells as they attach to the electrodes on the culture plates, but it cannot detect T-cells since they are suspension cells = a very simple, label-free assay where we can detect tumour cell death, and can easily separate out the T-cells

Come and See us at booth: F1 OR View Poster: 144 For more information